Patient info Open main menu

Colesevelam Hydrochloride 625 mg Film-Coated Tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
625 mg
Contains active substance:
Similar medicines:

Patient leaflet - Colesevelam Hydrochloride 625 mg film-coated tablets

1. What Colesevelam Hydrochloride tablets are and what it is used for

Colesevelam Hydrochloride tablets contains the active substance colesevelam (as hydrochloride). Taking Colesevelam Hydrochloride tablets helps to lower the level of cholesterol in your blood. Your doctor should only give you Colesevelam Hydrochloride tablets if a diet low in fat and cholesterol did not work well enough on its own.

Package leaflet: Information for the user

Colesevelam Hydrochloride 625 mg Film-Coated Tablets

colesevelam hydrochloride

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only.

    Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

  • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

If yo doc tabl Bef tabl con leve unt whi (ne

(dy

gall

u think any of these apply to you, you should inform your tor or pharmacist before taking Colesevelam Hydrochloride ets.

ore starting therapy with Colesevelam Hydrochloride ets, your physician should make sure that certain ditions do not contribute to your elevated cholesterol ls. These could include poorly controlled diabetes, reated hypothyroidism (low levels of thyroid hormone for ch no treatment is being given currently), proteins in urine phrotic syndrome), altered protein levels in the blood sproteinaemias), and blockage of the bile transport to your bladder (obstructive liver disease).

Children and adolescents

The safety and efficacy in children (below the age of 18 years) has not been studied. Therefore, Colesevelam Hydrochloride tablets is not recommended for use in this population.

Other medicines and Colesevelam Hydrochloride tablets

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

If your doctor suspects that Colesevelam Hydrochloride tablets may have an effect on the absorption of the other medication, you may be advised to take Colesevelam Hydrochloride tablets at least 4 hours before or at least 4 hours after taking the other medication. If you need to take other medicines more than once a day, remember that your Colesevelam Hydrochloride tablets can be taken once a day.

Colesevelam Hydrochloride tablets may affect the way in which the following medicines work:

  • Anticoagulant therapy (medicines, such as warfarin, used to thin blood). If you are taking anticoagulant therapy you should consult with your physician to closely monitor anticoagulation levels, as Colesevelam Hydrochloride tablets may affect the absorption of vitamin K and therefore interfere with the activity of warfarin.
  • Thyroid replacement therapy (medicines, such as thyroxine or levothyroxine, used to treat low thyroid hormone levels)
  • Oral contraceptives (medicines to prevent pregnancy) It is important you take Colesevelam Hydrochloride tablets at least 4 hours after you take the oral contraceptive to ensure that the effectiveness of the contraceptive is not affected.

1065045505

P1

P2

P3

P4

P5

P6

P7P8P9

P10

P11

P12

P13

P14

P15

P16

P17

P18

P19

P20

P21

P22

PC XXXXXXXXXXXXXX LOT XXXXXXXXX

EXP XXX.XXXX

Colesevelam Hydrochloride #625 mg

Film-Coated Tablets

Colesevelam Hydrochloride #625 mg

Film-Coated Tablets

Legislation check Infobox check

PM code (acc. Vista)

Product name (acc. Vista)

SAP ID / GMID (acc. Vista)

Braille (acc. AW process - scripts)

Technical check

Line spacing (minimum line spacing is 7 pt)

Used pictogram (check if correct pictogram is used, e.g. correct shape of tablet)

Content according to QRD + Using of proper paragraph style

According to approved templates (check alphabet and if special characters are applied correctly)

Text according to QRD or Annotated PDF (acc. Vista)

Brand name (check brand name on all sides where is applied)

Strenght (check strenght on all sides where is applied)

Pharmatheutical form (check pharmatheutical form on all sides where is applied)

INN (check INN on all sides where is applied)

Statement of active

substance(s) (QRD header 2)

Registration number

Design check
Corresponds to: design manual
country example
Consistence of AW (prev. AW or registred MO)
Used color for strength
Used color for brand name
TIN according to Vista
Bleed
Safe zones
Overprint

New version check

Update infobox (version and other data if needed)

Applied corrections (check if only requested corrections have been applied)

OK

OK

OK
OK
OK
OK

OK

OK

OK

OK

OK

OK

N/A

OK

OK

OK

OK

OK

OK

OK

OK

OK

OK OK

OK

OK

OK

OK
OK
OK
OK
OK
OK

OK

New MAA-ZN 9139-41; PL 1274, 75, 76;

MAA approved

Colesevelam Hydrochloride #625 mg

Film-Coated Tablets

Colesevelam

Hydrochloride

#625 mg

Film-Coated

Tablets

Helvetica Neue LT W1G 7 pt N/A

COLESEVELAM 625MG TAB BT180 GB Label/Leaflet

V10 REEL POSITION

COLOURS [ 4 ]

REASON FOR CHANGE

BRAILLE TEXT:

statin and the diet low in fat and cholesterol when patients are not appropriately controlled by the statin on its own.

  • Colesevelam Hydrochloride tablets may also be used together with ezetimibe (a cholesterol-lowering medicine that works by reducing cholesterol absorption from the gut), with or without a statin.

2. What you need to know before you take Colesevelam Hydrochloride tablets

Do not take Colesevelam Hydrochloride tablets:

  • if you are allergic to colesevelam hydrochloride or to any of the other ingredients of this medicine (listed in section 6)
  • if you have a blockage in your intestines or bile ducts (tubes that carry bile)

Colesevelam Hydrochloride tablets works in your intestinal system by binding bile acids produced by your liver and carrying the bile acids out of your body with your faeces. This prevents your body from recycling the bile acids from your intestines in the usual way. Without the recycling process, your liver has to make additional bile acids. Your liver uses cholesterol from your blood to do this, which lowers the level of cholesterol in your blood.

Colesevelam Hydrochloride tablets are prescribed to treat a condition known as primary hypercholesterolaemia (when cholesterol in the blood is elevated) in adults.

  • Colesevelam Hydrochloride tablets may be prescribed on its own in addition to a diet low in fat and cholesterol when treatment with a statin (a class of cholesterol-lowering medicines that work in the liver) is inappropriate or not well tolerated.
  • Colesevelam Hydrochloride tablets may be used together with a

3. How to take Colesevelam Hydrochloride tablets

Before starting therapy with Colesevelam Hydrochloride tablets, you should be advised to follow a cholesterol-lowering diet and you should continue this diet during treatment. Always take Colesevelam Hydrochloride tablets exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are unsure. As described in Section 2, if you will be taking Colesevelam Hydrochloride tablets along with another medicine it is possible that your doctor will advise you to take Colesevelam Hydrochloride tablets at least 4 hours before or at least 4 hours after taking the other medicine. If you take a medicine called either Neoral® or ciclosporin, please ensure to take it with Colesevelam Hydrochloride tablets in a consistent pattern over the day; either always

together or always separate for a set number of hours. You should take your Colesevelam Hydrochloride tablets with food and liquid. The tablets should be swallowed whole. Do not break, crush or chew the tablets.

Combination therapy:

The recommended dose for Colesevelam Hydrochloride tablets, when used with a statin or ezetimibe or both together, is 4 to 6 tablets a day by mouth. Your doctor may tell you to take Colesevelam Hydrochloride tablets dose either once a day or twice a day; in either case Colesevelam Hydrochloride tablets should be taken with a meal. The dosing of the statin and the ezetimibe should follow the instructions for that particular medicine. The medicines may be taken at the same time or at separate times according to what your doctor has prescribed.

Monotherapy:

The recommended dose for Colesevelam Hydrochloride tablets is 3 tablets taken twice a day with meals or 6 tablets a day with a meal. Your doctor may increase your dose to 7 tablets per day.

If you take more Colesevelam Hydrochloride tablets than you should

Please contact your doctor. Constipation or bloating could occur.

If you forget to take Colesevelam Hydrochloride tablets

You may take your dose with a later meal, but never take in one day more than the total number of tablets that your doctor has prescribed to you in a single day.

If you stop taking Colesevelam Hydrochloride tablets

Your cholesterol may increase to the level it was before treatment was started.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been reported in patients taking Colesevelam Hydrochloride tablets:

Very common (may affect more than 1 in 10 people): flatulence (wind), constipation.

Common (may affect up to 1 in 10 people): vomiting, diarrhoea, indigestion, abdominal pain, abnormal stools, feeling sick, bloating, headache, raised levels of triglycerides (fats) in your blood.

Uncommon (may affect up to 1 in 100 people): muscle pain, raised levels of liver enzymes in your blood, difficulty in swallowing.

Very rare (may affect up to 1 in 10,000 people): inflammation of the pancreas.

Not known (frequency cannot be estimated from the available data): blockage of the intestines (which can increase among patients with a history of blockage of the intestines or intestinal removal).

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist.

This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at:

http://www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Colesevelam Hydrochloride tablets

Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle label after “EXP’’

Keep the bottle tightly closed in order to protect from moisture.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Colesevelam Hydrochloride tablets contains

  • The active substance is colesevelam (as

    hydrochloride). Each tablet contains 625 mg colesevelam hydrochloride.

  • The other ingredients (excipients) are:

Tablet core:

Microcrystalline Cellulose (E460)

Colloidal Silicon Dioxide (E551)

If you are prescribed Colesevelam Hydrochloride tablets and any other medicine together you must also read the patient information leaflet that comes with that particular medicine before you start to take your medicine.

Warnings and precautions

Talk to your doctor or pharmacist before taking Colesevelam Hydrochloride tablets

  • if your triglyceride levels (a blood fat) are greater than 3.4 mmol/L
  • if you have difficulty in swallowing, or have a major stomach or intestinal disorder
  • if you suffer from constipation, as Colesevelam Hydrochloride tablets may induce or worsen this condition. This is especially important for patients with coronary heart disease and angina pectoris.

    Magnesium Stearate (E470b) Hypromellose (E464)

    Film-coating:

    Hypromellose (E464)

    Polyethylene Glycol (E1521) Printing ink:

    Ferrosoferric Oxide/Black iron oxide (E172) Shellac (E904)

    Propylene glycol (E1521) n-butyl alcohol

    Ammonium Hydroxide (E527)

    What Colesevelam Hydrochloride tablets looks like and contents of the pack

    Colesevelam Hydrochloride tablets are off white to light yellow, capsule shaped coated tablets with approximate dimensions of 19.3 mm x 9.9 mm, imprinted with 083 in black ink on one side and plain on other side and free from physical defects. The tablets are packed in plastic bottle containing Oxygen Absorber sachets with child resistant closures. Pack size is 180 (1 x 180) tablets.

    Marketing Authorisation Holder and Manufacturer

    Marketing Authorisation Holder

    Zentiva Pharma UK Limited,

    12 New Fetter Lane,

    London,

    EC4A 1JP, United Kingdom

    Manufacturer

    Wave Pharma Limited,

    Ground floor, Cavendish House,

    369 Burnt Oak Broadway, Edgware,

    Middlesex HA8 5AW, United Kingdom

    The name of this medicine is Colesevelam Hydrochloride 625 mg Film-Coated tablets (called Colesevelam Hydrochloride tablets throughout this leaflet).

    This leaflet was last revised in 09/2025

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 17780/1362

Last revision stated in the text: September 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Colesevelam Hydrochloride 625 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Colesevelam
Strength 625 mg
Pharmaceutical form Oral tablet
Cream to light yellow coloured with or without matte appearance, modified capsule shaped, biconvex, film coated tablets, imprinted '619' on one side and plain on other side.
The tablet length is approximately 20.0 mm, width is approximately 10.1 mm.
How is it taken Oral
Excipients Cellulose Microcrystalline, Crospovidone, Povidone, Silica Colloidal Anhydrous, Magnesium Stearate, Ferric Oxide Red (E 172), Ferric Oxide Yellow (E 172), Polyvinyl Alcohol-Part. Hydrolyzed, Talc, Titanium Dioxide (E 171), Macrogol/PEG, Methacrylic Acid and Ethyl Acrylate Copolymer, Sodium Bicarbonate, HPMC 2910/Hypromellose (E 464), Shellac Glaze~45% (20% Esterified) In Ethanol, Isopropyl Alcohol, Ferrosoferric Oxide (E 172), N-Butyl Alcohol, Ammonium Hydroxide 28%, Propylene Glycol
Pack sizes 180 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 36 months
After first opening use within 90 days.
Storage This product does not require any special temperature storage conditions.
Keep the bottle tightly closed in order to protect from moisture.
Drug group (ATC) Lipid modifying agent, bile acid sequestrants
  1. C Cardiovascular system drugs
    1. C10 Lipid modifying agents
      1. C10A Lipid modifying agents, plain
        1. C10AC Bile acid sequestrants
          1. C10AC04 colesevelam
Marketing authorisation PL 17780/1362, PL 58839/0100 (first authorised 27 August 2026)
Marketing authorisation holder Zydus Pharmaceuticals UK Ltd
Codes GTIN 8594739309326 · BNF 02120000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.